Previous clinical trials focus mainly on the exploration of lnc-MALAT1 in cancer patients, showing that lnc-MALAT1 plays a tumor-promotive role, while information about the role of lnc-MALAT1 in neurological diseases or cerebrovascular diseases is still limited (22, –24). The gene discussed is MALAT1; the disease is cancer.